NCT00334529View on ClinicalTrials.gov

Alternative Oseltamivir Dosing Strategies

PHASE2CompletedINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

June 5, 2006

Primary Completion Date

April 10, 2007

Study Completion Date

April 10, 2007

Conditions
Influenza
Interventions
DRUG

Oseltamivir

Trial Locations (4)

20892

National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda

94304

VA Greater Los Angeles Healthcare System, Los Angeles

VA Palo Alto Health Care System, Palo Alto

Unknown

Brooke Army Medical Center, Houston

All Listed Sponsors
lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

NCT00334529 - Alternative Oseltamivir Dosing Strategies | Biotech Hunter | Biotech Hunter